Cardiac Failure Flashcards

1
Q

Heart failure definition

A

Pathophysiological state in which the heart is unable to pump enough blood to meet the requirements of tissue metabolism, or needs an elevated filling pressure to do so.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pathiphysiology of HF

A

Reduced CO leads to sympathic activation and release of noradrenaline form adrenergic cardiac nerves. The RAAS and adrenergic system is activated.

  • The high LVEDP, LAP therefore high PCP.
  • Increased hydrostatic pressure gradient - increased fluid in interstitial tissues.
  • Increased pulmonary lymph flow
  • If lymphatic transport maximum exceeded then interstitial fluid accumulates.
  • If marked then alveolar fluid ‘invasion’.
  • Low CO leads to redistribution of blood flow, preserving flow to brain and heart at expense of skin, muscle, gut and kidney.
  • Ventricular remodelling with hypertrophy.
  • Endothelial dysfunction.
  • Over time, myocytes die, leading to fibrosis, reduced capillary density (hypertrophy, fibrosis) but added work (noradrenaline) leading to further ischaemic necrosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Natriurretic peptides

A
  • BNP: found in ventricles and atria
  • ANP: found in atria

Both released with increase in pressure and/or volume

  • Both cause natriuresis, vasodilatation.
  • BNP now used in diagnosis, assessment of severity and progress of treatment.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Affects of the RAAS system

A

Activation of renin-angiotensin-aldosterone system.

  • Retention of Na and water
    • Increased LVEDV therefore LVEDP
    • The rise in LVEDP is reflected back to LA and pulmonary veins and capillaries.
  • Angiotensin-2 potent vasoconstrictor
    • increased SVR
  • Angiotensin-2 potent stimulus to cell proliferation
    • hypertrophy
    • fibrosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Effects of the adrenergic system

A

Activation of adrenergic system

  • Increase in myocardial noradrenaline, toxic to myocytes
  • Increased SVR
  • Increased cardiac work
  • Progression of myocardial ischaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanisms of cardiac failure

A

Systolic failure

  • Reduced contractility (measured by ejection fraction)

Diastolic failure

  • Impaired relaxation
  • Increased wall stiffness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mechanisms of pulmonary oedema

A
  • Fluid movement into lung interstitial spaces depends on the balance offorces driving fluid out of the capillaries versus those forces holding fluid in the capillaries; and
  • Capillary surface are; and
  • Capillary permeability

Fluid fremoval from interstitial spaces via pulmonary lymphatics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PCP

A

Pulmonary capillary pressure depends on LAP - which itself depends on LVEDP.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diastolic dysfunction causes

A

Generally due to delayed relaxation (ischaemia) and reduced compliance with either LVH or myocardial infiltration or fibrosis as main causes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Intersitital fluid pressure

A

(IntP)

Usually negative (effect of the pressure generated by normal inspiration and surface tension in alveoli).

IntP rarely affects the rate of fluid movement except where marked increase in alveolar surface tension (e.g. loss of surfactant) or during mechanical ventilation where gas is pushed into lungs by positive pressures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Oncotic forces

A

Capillary normally impermeable to protein.

  • Plasma onconic pressure (Pl OncP) principally due to albumen and usually abotu 25mmHg.
  • Interstitial oncotic pressure (Int OncP) usually about 8-10mmHg.

Usual net balance is about +2-3mmHg causing a small fluid movement into interstitial space.

  • All entirely depenent on normal capillary permeability.

If this lost then fluid movement solely on hydrostatic pressure gradients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Presentation of cardiac failure

A

Acute

  • Dramatic onset
  • Pulmonary oedema
  • ‘small’ heart
  • RHF rare

Chronic

  • Slowly progressive onset
  • Pulmonary oedema rare
  • Cardiomegaly
  • RHF common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Causes of cardiac failure

A
  • HTN
  • Ischaemic heart disease
  • Dilated cardiomyopathy
    • Specific
    • Idiopathic
    • Tachycardia induced
  • Valvular heart disease
  • Dysrhythmias
  • HOCM
  • Restrictive cardiomyopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Right heart failure

A
  • Usually secondary to left heart fialure or chronically raised pulmonary capillary pressure and pulmonary hypertension.
  • COPD (cor pulmonale)
  • Primary pulmonary HTN
  • Other causes of RHF:
    • RV infarction - rare
    • RV cardiomyopathy - rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Symptoms of cardiac failure

A
  • Dyspnoea and fatigue
    • Significant exercise
    • Mild exercise
    • Trivial exercise
    • At rest
  • Orthopnoea
  • PND
  • Fatigue and exhaustion
  • Cough
  • Peripheral oedema
  • Tachycardia
  • Elevated venous pressure
  • Gallop rhythm
  • Lung crackles
  • Hepatomegaly
  • Peripheral vasoconstriction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Investigation of cardiac failure

A
  • ECG
  • Echocardiogram
  • CXR
  • Standard blood plus lipids and glucose
17
Q

Echo in cardiac failure

A
  • Regional dysfunction vs global, plus guesstimate of EF
  • LVH
  • State of values and severity of valve disease
  • HOC including outflow tract gradient
  • Diastolic dysfunction
18
Q

Management of cardiac failure

A

Establish cause - treat if possible.

  • IHD: consider angiography re vascularisation
  • Valvular disease: repair or replace the valve
  • HOCM: consider if role for surgical reduction or outflow tract gradient.
  • Treat any specific cardiomyopathy: sarcoid, amyloid, alcohol etc.

Volume control

  • diuretic, daily weight

Lifestyle measure

  • Salt restriction, physical activity

Block RAA system

  • ACEI
  • Receptor blockers

Block adrenergic system

  • Specific beta blockers: carvedilol, bisprolol improve outcome
  • Spironolactone improves outcome NYHA 3-4 failure
  • Epleronone improves outcome

Surgical management

  • Impanted defibrillator
  • Synchronised biventircular pacing
  • Left ventricular assist devices
  • Cardiac transplantation